<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01241149</url>
  </required_header>
  <id_info>
    <org_study_id>CIP# 10.0090</org_study_id>
    <nct_id>NCT01241149</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery</brief_title>
  <official_title>Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Naval Medical Center, Portsmouth</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Naval Medical Center, Portsmouth</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroesophageal reflux disease (GERD) is a common ailment affecting a significant portion of
      the US population. With the advent and increased use of esophageal impedance monitoring, both
      acid and nonacid reflux disease can be better diagnosed and treated. Patients with severe
      symptoms or symptoms refractory to medical management may be offered anti-reflux surgery for
      optimal treatment. Though there are a handful of studies evaluating the efficacy of
      anti-reflux surgery on those patients with acid or non-acid related reflux disease, the
      comparison between acid and non-acid reflux disease following surgery is lacking. We propose
      a prospective study comparing clinical outcomes from those patients with acid versus non-acid
      reflux disease following anti-reflux surgery with the use of validated and disease specific
      quality of life surveys.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of anti-reflux surgery</measure>
    <time_frame>1 year</time_frame>
    <description>To prospectively evaluate the effectiveness of anti-reflux surgery, as measured by symptom reduction, in the treatment of nonacid reflux disease compared prospectively with acid reflux disease.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Non-acid Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Normal pH, abnormal Impedance</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 24hr pH-metry and impedance, those patients with normal pH (i.e. DeMeester score &lt;14.7) but with abnormal impedance scores will be offered anti-reflux surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abnormal pH</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After 24hr pH-metry and impedance, those with abnormal pH scores (i.e. DeMeester score &gt;14.7)will be offered anti-reflux surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>anti-reflux surgery</intervention_name>
    <description>Anti-reflux surgery (Laparoscopic Nissen Fundoplication)</description>
    <arm_group_label>Normal pH, abnormal Impedance</arm_group_label>
    <arm_group_label>Abnormal pH</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are offered anti-reflux surgical treatment with elevated DeMeester scores
             or with low (less than 14.7) DeMeester scores, but with positive impedance scores
             (positive symptom index associated with reflux episodes).

        Exclusion Criteria:

          -  â€¢ Previous major upper gastrointestinal surgery (includes esophagus, stomach, and
             duodenum) - previous cholecystectomy (gallbladder removal) is not considered a major
             upper GI surgery

               -  Presence of paraesophageal hernia (type II - type IV)

               -  Presence of large hiatal hernia &gt;5cm

               -  Presence of peptic strictures

               -  History of severe esophageal motility disorders such as:

                    -  achalasia

                    -  diffuse esophageal spasms

                    -  scleroderma

                    -  poorly-controlled diabetes mellitus

                    -  autonomic or peripheral neuropathy

                    -  myopathy

               -  Pregnancy (As a standard operating procedure, women of child-bearing age will
                  undergo a urine pregnancy test the morning of surgery because anti-reflux surgery
                  is considered an elective case, where pregnancy is a relative contraindication.)

               -  BMI greater than 40

               -  Undergoes Collis gastroplasty during surgery

               -  Conversion to an open procedure

               -  Age less than 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellie Mentler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United States Naval Medical Center, Portsmouth</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ellie Mentler, MD</last_name>
    <phone>757-953-2454</phone>
    <email>ellie.mentler@med.navy.mil</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charles Morgan, PhD</last_name>
    <phone>757-953-5939</phone>
    <email>charles.morgan@med.navy.mil</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Naval Medical Center Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellie Mentler, MD</last_name>
      <phone>757-953-2454</phone>
      <email>ellie.mentler@med.navy.mil</email>
    </contact>
    <contact_backup>
      <last_name>Charles Morgan, PhD</last_name>
      <phone>757-953-5939</phone>
      <email>charles.morgan@med.navy.mil</email>
    </contact_backup>
    <investigator>
      <last_name>Ellie Mentler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cade Cinnamond, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Barker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Smith, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Gentry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delores Rhodes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2010</study_first_submitted>
  <study_first_submitted_qc>November 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2010</study_first_posted>
  <last_update_submitted>November 15, 2010</last_update_submitted>
  <last_update_submitted_qc>November 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>LT Ellie Mentler</name_title>
    <organization>Naval Medical Center Portsmouth</organization>
  </responsible_party>
  <keyword>Nissen fundoplication</keyword>
  <keyword>non-acid reflux disease</keyword>
  <keyword>anti-reflux surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

